Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$203,265
New position
Shares Held
1,297
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,314
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aviance Capital Partners, LLC holds $78,033,539 across 10 Drug Manufacturers - General names. NVS ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
147,328 | $37,073,617 | |
| 2 | AMGN |
Amgen Inc
|
36,998 | $13,397,715 | |
| 3 | JNJ |
Johnson & Johnson
|
36,810 | $9,348,635 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,110 | $5,411,135 | |
| 5 | PFE |
Pfizer Inc
|
159,351 | $3,837,172 | |
| 6 | LLY |
ELI LILLY & Co
|
3,181 | $3,815,387 | |
| 7 | NVO |
Novo Nordisk A S
|
49,981 | $2,396,089 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,102 | $1,849,717 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $203,265 | 1,297 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||